Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Amin

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The British Journal of Surgery|November 1, 1994
Interstitial laser photocoagulation as a treatment for breast cancerS A Harries, Z Amin, M E Smith, et al.
Emerging Infectious Diseases|December 19, 2001
Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatmentR van Crevel, R H Nelwan, W de Lenne, et al.
Radiology|September 1, 1996
Laser therapy for breast cancer: MR imaging and histopathologic correlationH Mumtaz, M A Hall-Craggs, A Wotherspoon, et al.
The Journal of Hospital Infection|February 8, 2025
Pathogenic bacteria rapidly colonize sinks of a neonatal intensive care unit: results of a prospective surveillance studyJ M Low, K K K Ko, R T H Ong, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 1, 2022
Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant womenH Blakeway, Z Amin-Chowdhury, S Prasad, et al.
American Journal of Clinical Dermatology|July 29, 2025
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial ResultsKim A Papp, Mark G Lebwohl, Lluís Puig, et al.
Journal of the American Academy of Dermatology|August 8, 2023
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-upKim A Papp, Andrew Blauvelt, Lluís Puig, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The British Journal of Surgery|November 1, 1994
Interstitial laser photocoagulation as a treatment for breast cancerS A Harries, Z Amin, M E Smith, et al.
Emerging Infectious Diseases|December 19, 2001
Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatmentR van Crevel, R H Nelwan, W de Lenne, et al.
Radiology|September 1, 1996
Laser therapy for breast cancer: MR imaging and histopathologic correlationH Mumtaz, M A Hall-Craggs, A Wotherspoon, et al.
The Journal of Hospital Infection|February 8, 2025
Pathogenic bacteria rapidly colonize sinks of a neonatal intensive care unit: results of a prospective surveillance studyJ M Low, K K K Ko, R T H Ong, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 1, 2022
Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant womenH Blakeway, Z Amin-Chowdhury, S Prasad, et al.
American Journal of Clinical Dermatology|July 29, 2025
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial ResultsKim A Papp, Mark G Lebwohl, Lluís Puig, et al.
Journal of the American Academy of Dermatology|August 8, 2023
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-upKim A Papp, Andrew Blauvelt, Lluís Puig, et al.
Pageof 8